{"edition":"new-york-city","organization":"Newark Community Street Team","organizationId":"org:newark-community-street-team","boundaryVersion":"OMB-23-01-2023-07-21","updated":"2026-10-08","display":{"metric":{"id":"daly-equivalent","years":1,"label":"DALY","priceLabel":"$ / DALY"},"priceUSD":5595033.016346672,"canonicalPriceUSDPerTenEquivalentYears":55950330.163466714,"conversion":"display only; QALYs and income equivalents are not measured clinical DALYs"},"listDisplay":{"metric":{"id":"daly-equivalent","years":1,"label":"DALY","priceLabel":"$ / DALY"},"priceUSD":5595033.016346672,"canonicalPriceUSDPerTenEquivalentYears":55950330.163466714,"conversion":"display only; QALYs and income equivalents are not measured clinical DALYs"},"model":{"version":"nyc-ncst-targeted-resources-assessed-unknown-v2","costScope":"Full recipient annual forward resource cost, including donated services and unpriced programs. Partial multi-pathway clinical denominator; not all portfolio value.","geographicAttribution":"Newark is in Essex County within the official 22-county NYC MSA. g=0.98 is a direct-beneficiary retention prior, not a headquarters-based share of national CBPSC work.","formula":"F(r,T)=(1-exp(-(r+ln(1+d))*T))/(r+ln(1+d)). V=oV*[M*fM*pM+H*fH*l*(r0-OR*r0/(1-r0+OR*r0))]. QV=V*[(1-z)*ui*F(ri,Ti)+z*ud*F(md,Td)]. QT=T*fT*pT*uT*F(rT,TT). QR=R*oR*tR*deltaR*uR*F(mR,TR). Q_all=a*b*(QV+QT+QR-h); Q_NYC=g*Q_all; price=10*C/Q_NYC if positive, else null. V counts unique newly prevented violent injuries, QT existing-survivor recovery, QR unique overdose survival. Effects are valued at onset; one-year delay multiplies Q by 1/1.03.","counterfactual":"Emergency medical response, ordinary hospital/mental-health care, funded local safety programs and natural recovery continue. External HVIP evidence is attenuated before assigning NCST’s contribution; overdose timely-rescue substitution is modeled explicitly. Funding response b applies once, not again per program.","attribution":"No causal credit for city crime trends, public meeting attendance or historical program existence. The priced pathways span the central clinical mission, while Safe Passage’s broader safety, community organizing, housing and national learning effects are explicitly unpriced. a is contribution within delivered care, not another donor multiplier. Existing-trauma utility gains must be additional on person-time alive in both arms and exclude utility already included in newly added survival years. The overdose unique-person adjustment must also remove repeat rescues and any survivor already credited a prevented violent death. These are modeling assumptions, not observed linked-person exclusions.","uncertainty":"Clinical conversion, native event risks, current annual reach, overlap and funding response are judgments. The range is not a statistical interval; pooled OR confidence limits are only ingredients in broader scenarios. Negative effects and zero are possible.","nativeOutcomes":"Distinct high-risk mediation opportunities and current hospital enrollments translated to net new violent injuries prevented. Existing-survivor clinical episodes translated to incremental finite trauma recovery. Naloxone reversals deduplicated to people with incremental timely rescue and finite survival.","inputs":[{"name":"C","value":6443440,"unit":"USD annual whole-recipient forward resource cost","basis":"observed","rationale":"Audited expense 6,286,421 plus reversal of the 157,019 prior receivable-recovery credit; this is a forward-cost normalization, not extra audited spending.","sourceIds":["audit2024","d2024"]},{"name":"M","value":119,"unit":"reported mediations in 2024","basis":"observed","rationale":"Part III reported 119; not the evaluation’s differently defined and much larger logged HRI event count.","sourceIds":["return2024"]},{"name":"fM","value":0.6,"unit":"fraction representing distinct current-year effective mediation opportunities","basis":"judgment","rationale":"60% prior handles repeat conflicts, unique opportunities and current capacity; no claim of audited reach.","sourceIds":["evaluation"]},{"name":"pM","value":0.03,"unit":"net violent injury probability reduction per effective mediation","basis":"judgment","rationale":"3 percentage points net difference for one-year mediation opportunity, not 3% of all city crime.","sourceIds":["evaluation"]},{"name":"H","value":137,"unit":"reported hospital-program consents","basis":"observed","rationale":"Part III says 137 consents; the same number occurs in an older return narrative, so treat temporal accuracy as uncertain.","sourceIds":["return2024"]},{"name":"fH","value":0.8,"unit":"fraction representing effective current annual hospital enrollments","basis":"judgment","rationale":"80% current-effective fraction; original reported consents are not verified unique current completions.","sourceIds":["evaluation"]},{"name":"r0","value":0.1,"unit":"two-year violent reinjury risk without HVIP","basis":"judgment","rationale":"10% two-year untreated reinjury risk is a local prior, not supplied by the external pooled odds ratio.","sourceIds":["hvip2026"]},{"name":"OR","value":0.6,"unit":"odds ratio of violent reinjury, external review","basis":"observed","rationale":"0.60 (95% CI 0.38–0.94), 10-study meta-analysis; low quality and heterogeneous, not NCST causal evidence.","sourceIds":["hvip2026"]},{"name":"l","value":0.5,"unit":"local transfer fraction of external risk difference","basis":"judgment","rationale":"Half the external risk difference retained for local delivery and population transfer.","sourceIds":["hvip2026"]},{"name":"oV","value":0.8,"unit":"non-overlapping fraction of combined violence prevention","basis":"judgment","rationale":"20% deducted for overlap between mediation and hospital pathways; also avoids separately adding Safe Passage injuries.","sourceIds":["evaluation"]},{"name":"z","value":0.05,"unit":"fatal share of prevented violent injuries","basis":"judgment","rationale":"5% fatality mix prior for prevented serious violent injuries; not a measured NCST outcome.","sourceIds":["evaluation"]},{"name":"ui","value":0.2,"unit":"utility burden of nonfatal violent injury","basis":"judgment","rationale":"Physical and trauma burden of a new nonfatal injury; not a fiscal crime-cost conversion.","sourceIds":["evaluation"]},{"name":"ri","value":0.5,"unit":"annual nonfatal injury recovery rate","basis":"judgment","rationale":"Recovery 0.5 annually; avoids permanent disability assumptions.","sourceIds":["evaluation"]},{"name":"Ti","value":3,"unit":"years nonfatal injury horizon","basis":"judgment","rationale":"Finite three years.","sourceIds":["evaluation"]},{"name":"ud","value":0.8,"unit":"survivor utility after prevented violent death","basis":"judgment","rationale":"0.8 health-adjusted survival rather than full-quality life.","sourceIds":["evaluation"]},{"name":"md","value":0.02,"unit":"annual competing mortality hazard","basis":"judgment","rationale":"2% competing annual mortality; unique victims counted once.","sourceIds":["evaluation"]},{"name":"Td","value":20,"unit":"years violent-death survival horizon","basis":"judgment","rationale":"Finite 20-year horizon.","sourceIds":["evaluation"]},{"name":"T","value":265,"unit":"reported trauma-program participants","basis":"observed","rationale":"Return reports 265 participants alongside 202 clients described cumulatively; cannot interpret both as annual distinct totals.","sourceIds":["return2024"]},{"name":"fT","value":0.5,"unit":"fraction representing unique effective annual trauma episodes","basis":"judgment","rationale":"50% prior for annual unique completed clinical episodes, removing ambiguous reach and attendance duplication.","sourceIds":["evaluation"]},{"name":"pT","value":0.15,"unit":"incremental trauma responders per episode","basis":"judgment","rationale":"15% extra recovery beyond natural recovery and ordinary care; not observed locally.","sourceIds":["evaluation"]},{"name":"uT","value":0.15,"unit":"utility improvement per trauma responder","basis":"judgment","rationale":"0.15 utility gain among extra responders, not a validated scale conversion.","sourceIds":["evaluation"]},{"name":"rT","value":0.5,"unit":"annual trauma-effect decay","basis":"judgment","rationale":"Effect decays at 0.5 annually.","sourceIds":["evaluation"]},{"name":"TT","value":2,"unit":"years trauma follow-up","basis":"judgment","rationale":"Finite two-year trauma benefit; existing injuries only, distinct from prevented new injuries.","sourceIds":["evaluation"]},{"name":"R","value":30,"unit":"reported naloxone reversals","basis":"observed","rationale":"30 reported reversals in 2024; neither 30 deaths prevented nor 30 necessarily unique people.","sourceIds":["return2024"]},{"name":"oR","value":0.7,"unit":"unique-person fraction of reversals","basis":"judgment","rationale":"70% unique-person prior to prevent repeat-rescue lifetime double counting.","sourceIds":["return2024","naloxone","heal"]},{"name":"tR","value":0.2,"unit":"fraction without otherwise timely effective rescue","basis":"judgment","rationale":"20% would lack timely alternative rescue; 27 arrivals before EMS does not identify this parameter.","sourceIds":["return2024","naloxone","heal"]},{"name":"deltaR","value":0.2,"unit":"mortality risk reduction in that rescue subset","basis":"judgment","rationale":"20% absolute mortality difference within the otherwise untimely-rescue subset, not among all contacts.","sourceIds":["return2024","naloxone","heal"]},{"name":"uR","value":0.65,"unit":"utility among overdose survivors","basis":"judgment","rationale":"0.65 utility, reflecting morbidity in a high-risk rescued cohort.","sourceIds":["evaluation"]},{"name":"mR","value":0.1,"unit":"annual competing mortality hazard after rescue","basis":"judgment","rationale":"10% annual competing mortality includes subsequent fatal overdose and other causes.","sourceIds":["return2024","naloxone","heal"]},{"name":"TR","value":10,"unit":"years overdose survival horizon","basis":"judgment","rationale":"Finite 10-year survival; no automatic lifetime credit or extra post-rescue SUD benefit.","sourceIds":["evaluation"]},{"name":"a","value":0.5,"unit":"NCST attributable service share within the delivery ecosystem","basis":"judgment","rationale":"50% recipient contribution within hospital, emergency and clinical partnerships; no credit for the whole local coalition.","sourceIds":["current","audit2024"]},{"name":"b","value":0.25,"unit":"ordinary donor funding-response fraction","basis":"judgment","rationale":"25% marginal response to an ordinary gift; public contracts, reserve substitution and referral limits persist.","sourceIds":["current","audit2024"]},{"name":"g","value":0.98,"unit":"NYC MSA fraction of priced health","basis":"judgment","rationale":"98% because modeled direct pathways serve Newark, allowing migration outside official 22-county MSA. National CBPSC benefits excluded.","sourceIds":["current","audit2024"]},{"name":"h","value":0,"unit":"additional QALY harm before attribution/funding multipliers","basis":"judgment","rationale":"Zero central; one additional QALY of harm in adverse scenario beyond increased violent injury.","sourceIds":["evaluation"]},{"name":"d","value":0.03,"unit":"annual discount rate","basis":"judgment","rationale":"3% annually; continuous-equivalent log(1+d).","sourceIds":["evaluation"]}],"scenarios":[{"id":"central","label":"Conditional multi-pathway health central","costUSD":6443440,"allPopulationQalys":1.175138512373493,"editionQalys":1.151635742126023,"pricePer10Qalys":55950330.163466714,"assumptions":"{\"C\":6443440,\"M\":119,\"fM\":0.6,\"pM\":0.03,\"H\":137,\"fH\":0.8,\"r0\":0.1,\"OR\":0.6,\"l\":0.5,\"oV\":0.8,\"z\":0.05,\"ui\":0.2,\"ri\":0.5,\"Ti\":3,\"ud\":0.8,\"md\":0.02,\"Td\":20,\"T\":265,\"fT\":0.5,\"pT\":0.15,\"uT\":0.15,\"rT\":0.5,\"TT\":2,\"R\":30,\"oR\":0.7,\"tR\":0.2,\"deltaR\":0.2,\"uR\":0.65,\"mR\":0.1,\"TR\":10,\"a\":0.5,\"b\":0.25,\"g\":0.98,\"h\":0,\"d\":0.03}"},{"id":"low","label":"Low current reach and incremental benefit","costUSD":6443440,"allPopulationQalys":0.02306550271909557,"editionQalys":0.022604192664713658,"pricePer10Qalys":2850550822.838522,"assumptions":"{\"C\":6443440,\"M\":119,\"fM\":0.3,\"pM\":0.005,\"H\":137,\"fH\":0.5,\"r0\":0.1,\"OR\":0.94,\"l\":0.25,\"oV\":0.8,\"z\":0.05,\"ui\":0.2,\"ri\":0.5,\"Ti\":3,\"ud\":0.8,\"md\":0.02,\"Td\":20,\"T\":265,\"fT\":0.25,\"pT\":0.03,\"uT\":0.15,\"rT\":0.5,\"TT\":2,\"R\":30,\"oR\":0.7,\"tR\":0.05,\"deltaR\":0.1,\"uR\":0.65,\"mR\":0.1,\"TR\":10,\"a\":0.25,\"b\":0.1,\"g\":0.98,\"h\":0,\"d\":0.03}"},{"id":"high","label":"Higher clinical reach and incremental benefit","costUSD":6443440,"allPopulationQalys":11.349192335868361,"editionQalys":11.122208489150994,"pricePer10Qalys":5793309.85054377,"assumptions":"{\"C\":6443440,\"M\":119,\"fM\":0.9,\"pM\":0.08,\"H\":137,\"fH\":1,\"r0\":0.1,\"OR\":0.38,\"l\":0.75,\"oV\":0.8,\"z\":0.05,\"ui\":0.2,\"ri\":0.5,\"Ti\":3,\"ud\":0.8,\"md\":0.02,\"Td\":20,\"T\":265,\"fT\":0.8,\"pT\":0.3,\"uT\":0.15,\"rT\":0.5,\"TT\":2,\"R\":30,\"oR\":0.7,\"tR\":0.4,\"deltaR\":0.3,\"uR\":0.65,\"mR\":0.1,\"TR\":10,\"a\":0.75,\"b\":0.5,\"g\":0.98,\"h\":0,\"d\":0.03}"},{"id":"zero","label":"No marginal funding response","costUSD":6443440,"allPopulationQalys":0,"editionQalys":0,"pricePer10Qalys":null,"assumptions":"{\"C\":6443440,\"M\":119,\"fM\":0.6,\"pM\":0.03,\"H\":137,\"fH\":0.8,\"r0\":0.1,\"OR\":0.6,\"l\":0.5,\"oV\":0.8,\"z\":0.05,\"ui\":0.2,\"ri\":0.5,\"Ti\":3,\"ud\":0.8,\"md\":0.02,\"Td\":20,\"T\":265,\"fT\":0.5,\"pT\":0.15,\"uT\":0.15,\"rT\":0.5,\"TT\":2,\"R\":30,\"oR\":0.7,\"tR\":0.2,\"deltaR\":0.2,\"uR\":0.65,\"mR\":0.1,\"TR\":10,\"a\":0.5,\"b\":0,\"g\":0.98,\"h\":0,\"d\":0.03}"},{"id":"adverse","label":"Increased conflict and no clinical gains","costUSD":6443440,"allPopulationQalys":-0.31570976421493113,"editionQalys":-0.3093955689306325,"pricePer10Qalys":null,"assumptions":"{\"C\":6443440,\"M\":119,\"fM\":0.6,\"pM\":-0.02,\"H\":137,\"fH\":0.8,\"r0\":0.1,\"OR\":1.1,\"l\":1,\"oV\":0.8,\"z\":0.05,\"ui\":0.2,\"ri\":0.5,\"Ti\":3,\"ud\":0.8,\"md\":0.02,\"Td\":20,\"T\":265,\"fT\":0.5,\"pT\":0,\"uT\":0.15,\"rT\":0.5,\"TT\":2,\"R\":30,\"oR\":0.7,\"tR\":0,\"deltaR\":0.2,\"uR\":0.65,\"mR\":0.1,\"TR\":10,\"a\":0.5,\"b\":0.25,\"g\":0.98,\"h\":1,\"d\":0.03}"},{"id":"no-overdose","label":"No additional overdose survival","costUSD":6443440,"allPopulationQalys":0.7925519270947587,"editionQalys":0.7767008885528636,"pricePer10Qalys":82959091.3949553,"assumptions":"{\"C\":6443440,\"M\":119,\"fM\":0.6,\"pM\":0.03,\"H\":137,\"fH\":0.8,\"r0\":0.1,\"OR\":0.6,\"l\":0.5,\"oV\":0.8,\"z\":0.05,\"ui\":0.2,\"ri\":0.5,\"Ti\":3,\"ud\":0.8,\"md\":0.02,\"Td\":20,\"T\":265,\"fT\":0.5,\"pT\":0.15,\"uT\":0.15,\"rT\":0.5,\"TT\":2,\"R\":30,\"oR\":0.7,\"tR\":0,\"deltaR\":0.2,\"uR\":0.65,\"mR\":0.1,\"TR\":10,\"a\":0.5,\"b\":0.25,\"g\":0.98,\"h\":0,\"d\":0.03}"},{"id":"no-violence","label":"No additional violent injury prevention","costUSD":6443440,"allPopulationQalys":0.8422774647203783,"editionQalys":0.8254319154259707,"pricePer10Qalys":78061435.22660874,"assumptions":"{\"C\":6443440,\"M\":119,\"fM\":0.6,\"pM\":0,\"H\":137,\"fH\":0.8,\"r0\":0.1,\"OR\":1,\"l\":0.5,\"oV\":0.8,\"z\":0.05,\"ui\":0.2,\"ri\":0.5,\"Ti\":3,\"ud\":0.8,\"md\":0.02,\"Td\":20,\"T\":265,\"fT\":0.5,\"pT\":0.15,\"uT\":0.15,\"rT\":0.5,\"TT\":2,\"R\":30,\"oR\":0.7,\"tR\":0.2,\"deltaR\":0.2,\"uR\":0.65,\"mR\":0.1,\"TR\":10,\"a\":0.5,\"b\":0.25,\"g\":0.98,\"h\":0,\"d\":0.03}"},{"id":"audited-cost","label":"Unadjusted audited expense","costUSD":6286421,"allPopulationQalys":1.175138512373493,"editionQalys":1.151635742126023,"pricePer10Qalys":54586886.89528429,"assumptions":"{\"C\":6286421,\"M\":119,\"fM\":0.6,\"pM\":0.03,\"H\":137,\"fH\":0.8,\"r0\":0.1,\"OR\":0.6,\"l\":0.5,\"oV\":0.8,\"z\":0.05,\"ui\":0.2,\"ri\":0.5,\"Ti\":3,\"ud\":0.8,\"md\":0.02,\"Td\":20,\"T\":265,\"fT\":0.5,\"pT\":0.15,\"uT\":0.15,\"rT\":0.5,\"TT\":2,\"R\":30,\"oR\":0.7,\"tR\":0.2,\"deltaR\":0.2,\"uR\":0.65,\"mR\":0.1,\"TR\":10,\"a\":0.5,\"b\":0.25,\"g\":0.98,\"h\":0,\"d\":0.03}"},{"id":"external-cost","label":"Additional treatment and emergency resources","costUSD":6607877.5,"allPopulationQalys":1.175138512373493,"editionQalys":1.151635742126023,"pricePer10Qalys":57378190.50146242,"assumptions":"{\"C\":6607877.5,\"M\":119,\"fM\":0.6,\"pM\":0.03,\"H\":137,\"fH\":0.8,\"r0\":0.1,\"OR\":0.6,\"l\":0.5,\"oV\":0.8,\"z\":0.05,\"ui\":0.2,\"ri\":0.5,\"Ti\":3,\"ud\":0.8,\"md\":0.02,\"Td\":20,\"T\":265,\"fT\":0.5,\"pT\":0.15,\"uT\":0.15,\"rT\":0.5,\"TT\":2,\"R\":30,\"oR\":0.7,\"tR\":0.2,\"deltaR\":0.2,\"uR\":0.65,\"mR\":0.1,\"TR\":10,\"a\":0.5,\"b\":0.25,\"g\":0.98,\"h\":0,\"d\":0.03}"},{"id":"resource-cost","label":"25% additional resource costs","costUSD":8054300,"allPopulationQalys":1.175138512373493,"editionQalys":1.151635742126023,"pricePer10Qalys":69937912.7043334,"assumptions":"{\"C\":8054300,\"M\":119,\"fM\":0.6,\"pM\":0.03,\"H\":137,\"fH\":0.8,\"r0\":0.1,\"OR\":0.6,\"l\":0.5,\"oV\":0.8,\"z\":0.05,\"ui\":0.2,\"ri\":0.5,\"Ti\":3,\"ud\":0.8,\"md\":0.02,\"Td\":20,\"T\":265,\"fT\":0.5,\"pT\":0.15,\"uT\":0.15,\"rT\":0.5,\"TT\":2,\"R\":30,\"oR\":0.7,\"tR\":0.2,\"deltaR\":0.2,\"uR\":0.65,\"mR\":0.1,\"TR\":10,\"a\":0.5,\"b\":0.25,\"g\":0.98,\"h\":0,\"d\":0.03}"},{"id":"combined-income-unknown","label":"Combined resources unknown; clinical reference retained","costUSD":6443440,"allPopulationQalys":1.175138512373493,"editionQalys":1.151635742126023,"incomeUnknown":true,"assumptions":"Original clinical model and full annual recipient resource scope retained; signed household resources unknown, not zero."}],"sensitivity":["The range varies current-effective reach rather than treating repeated historical counts as confirmed annual capacity.","The no-overdose and no-violence scenarios expose dependence on each material clinical channel.","Survival is finite and discounted with competing mortality; no rescued person receives multiple lives.","The adverse case permits net escalation, worse reinjury and separate harm.","The external-cost case adds $5,000 per donor-attributable hospital, trauma and unique rescue episode; resource and audited-cost alternatives are separate.","Attribution and funding response each apply once; zero funding elasticity eliminates all marginal health."],"missingInputs":["Reconciled current annual unique clients, mediations, repeat responses and cross-program overlap.","Matched or randomized injury and trauma outcomes, all-referral follow-up and a defensible untreated reinjury risk.","Unique overdose patients, arrival-time counterfactual, clinical severity and later mortality.","Current contract renewals, funding restrictions and the actual capacity opened or protected by an ordinary gift.","External treatment resources, induced emergency costs and incremental school/community spillovers.","Post-2024 audited finances and sustained financial-control implementation.","Deduplicated funding-responsive households, actual assistance paid and retained compensation, displaced private payments versus free alternatives, household net baseline, full access/work burdens, finite timing and payer incidence."],"incomeAssessment":{"status":"assessed-unknown","materiality":"targeted","acceptance":"independently-reviewed","evidence":"docs/geography-discovery/nyc-ncst-alpha-income-20261008/root-acceptance.md","sourceIds":["current"],"rationale":"Current operational services include hardship assistance, compensation applications, free therapy and legal support. The $200 assistance ceiling is not a realized average or a gift-responsive household count. Actual private-payment displacement, retained compensation and employment resources are unidentified.","directions":["Potential retained hardship assistance and victim compensation, actual displaced private therapy/legal payments and work access.","Full participant time, travel, administration and work costs independent of clinical response; taxes and withdrawn benefits; existing funded services and alternative providers.","Provider/public financing and compensation transfers have separate payer incidence; broader employment effects remain unquantified."],"missing":"Deduplicated funding-responsive households, actual assistance paid and retained compensation, displaced private payments versus free alternatives, household net baseline, full access/work burdens, finite timing and payer incidence."}},"sources":[{"id":"return2024","title":"FY2024 original Form 990","url":"https://projects.propublica.org/nonprofits/full_text/202502749349300100/IRS990","publisher":"NCST / IRS","published":null,"retrieved":"2026-09-14"},{"id":"d2024","title":"FY2024 Schedule D donated-service reconciliation","url":"https://projects.propublica.org/nonprofits/full_text/202502749349300100/IRS990ScheduleD","publisher":"NCST / IRS","published":null,"retrieved":"2026-09-14"},{"id":"audit2024","title":"FY2024 original audited financial statements and findings","url":"https://projects.propublica.org/nonprofits/display_audit/2024-12-GSAFAC-0000381354","publisher":"Brunhofer & Balise, LLP / NCST","published":null,"retrieved":"2026-09-14"},{"id":"return2023","title":"FY2023 original Form 990","url":"https://projects.propublica.org/nonprofits/full_text/202541189349300229/IRS990","publisher":"NCST / IRS","published":null,"retrieved":"2026-09-14"},{"id":"d2023","title":"FY2023 original Schedule D reconciliation","url":"https://projects.propublica.org/nonprofits/full_text/202541189349300229/IRS990ScheduleD","publisher":"NCST / IRS","published":null,"retrieved":"2026-09-14"},{"id":"audit2023","title":"FY2023 original audit and corrective actions","url":"https://projects.propublica.org/nonprofits/display_audit/2023-12-GSAFAC-0000360537","publisher":"Brunhofer & Balise, LLP / NCST","published":null,"retrieved":"2026-09-14"},{"id":"return2022","title":"FY2022 original Form 990","url":"https://projects.propublica.org/nonprofits/full_text/202411279349301321/IRS990","publisher":"NCST / IRS","published":null,"retrieved":"2026-09-14"},{"id":"d2022","title":"FY2022 original Schedule D reconciliation","url":"https://projects.propublica.org/nonprofits/full_text/202411279349301321/IRS990ScheduleD","publisher":"NCST / IRS","published":null,"retrieved":"2026-09-14"},{"id":"evaluation","title":"NCST Evaluation and Proof of Concept, November 2025","url":"https://www.newarkcommunitystreetteam.org/wp-content/uploads/2026/03/NCST-Evaluation-and-Proof-of-Concept-2025-FINAL-.pdf","publisher":"Leap et al. / UCLA evaluation commissioned by CBPSC and funded by Ford Foundation","published":null,"retrieved":"2026-09-14"},{"id":"current","title":"Current programs","url":"https://www.newarkcommunitystreetteam.org/what-we-do/","publisher":"Newark Community Street Team","published":null,"retrieved":"2026-10-08"},{"id":"donate","title":"Ordinary donation route","url":"https://www.newarkcommunitystreetteam.org/donate/","publisher":"Newark Community Street Team","published":null,"retrieved":"2026-09-14"},{"id":"hvip2026","title":"Hospital violence intervention systematic review and guideline, 2026 update","url":"https://pubmed.ncbi.nlm.nih.gov/42611686/","publisher":"Jawa et al. / Journal of Trauma and Acute Care Surgery","published":"2026-08-18","retrieved":"2026-09-14"},{"id":"hvip2016","title":"Earlier review finding insufficient adult HVIP evidence","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5891700/","publisher":"Affinati et al. / Trauma Surgery & Acute Care Open","published":"2016-09-28","retrieved":"2026-09-14"},{"id":"naloxone","title":"Overdose education and naloxone distribution interrupted time-series study","url":"https://pubmed.ncbi.nlm.nih.gov/23372174/","publisher":"Walley et al. / BMJ","published":null,"retrieved":"2026-09-14"},{"id":"heal","title":"Community-based cluster-randomized trial to reduce opioid overdose deaths","url":"https://pubmed.ncbi.nlm.nih.gov/38884347/","publisher":"HEALing Communities Study / New England Journal of Medicine","published":null,"retrieved":"2026-09-14"}]}